NSYS vs REGN · P/E 44, rev $14.4M vs P/E 14, rev $14.34B
Nortech Systems Incorporated (NSYS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Nortech Systems Incorporated (NSYS) is a medical devices company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NSYS revenue for 2024-12-31 was $14.4M. Net income was -$1.3M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. NSYS currently screens at market cap $46.2M and trailing P/E 43.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NSYS currently screens at market cap $46.2M and trailing P/E 43.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NSYS and REGN stock pages for the full models.
Not investment advice.